Palbociclib Combined With Fulvestrant in Relapsed Metastatic HR+/HER2- Breast Cancer

(2:2)

Palbociclib: single-agent or in combination for the treatment of breast cancer

(6:47)

ENGOT-EN3-NSGO/PALEO: Letrozole-palbociclib combination for endometrial cancer

(5:34)

AFT-38 PATINA: the role of palbociclib in combination in HR+/HER2+ metastatic breast cancer

(3:18)

Palbociclib and Letrozole for Advanced Breast Cancer

(2:5)

PALBOCICLIB AND LETROZOLE FOR MY METASTATIC BREAST CANCER

(24:24)

palbociclib side-effects and what I did for that #winlifedefeatcancer #palbociclib#breastcancer

(7:2)

Cancer Metastasis in the Bones - All Symptoms

(8:21)

Breakthrough: Inavolisib Combo Wins FDA Nod for Breast Cancer

(13:38)

BCFNZ Webinar: Life on Ibrance Long-term

(38:28)

PARP Inhibitors in 2020: Where Are We Now, and Where Are We Going | Webinar | Ambry Genetics

(54:40)

First Night Taking Ibrance and Letrozole | Stage 4 Metastatic Breast Cancer Warrior

(4:35)

What are CDK 4/6 Inhibitors for Breast Cancer?

(7:59)

Palbociclib (IBRANCE) Revs Up Metastatic Breast Cancer in PATINA Results - SABCS - Otto Metzger, MD

(14:38)

Anti-HER2 Mechanisms of Approved HER2 Inhibitors

(5:5)

PENELOPE-B: palbociclib with endocrine therapy in HR+, HER2-negative breast cancer

(5:)

Palbociclib combinations on treatment of advanced breast cancer – Video abstract [ID 77033]

(13:24)

Palbociclib, pembrolizumab, and endocrine therapy in HR+/HER2- breast cancer

(1:10)

PALOMA-3: palbociclib and fulvestrant for HR-/HER+ metastatic breast cancer

(5:4)

PATRICIA: Phase II study of palbociclib, trastuzumab, and endocrine therapy in HER2+ advanced BC

(44)

Real-world clinical outcomes in metastatic breast cancer patients treated with palbociclib

(1:45)

Palbociclib in the management of breast cancer - Video abstract [46725]

(1:26)

ASCO 2024 Palbociclib, Pembrolizumab \u0026 Endocrine Therapy: Outcomes \u0026 Gut Microbiome in HR+/HER2- MBC

(4:19)

PARSIFAL-LONG: fulvestrant and palbociclib vs letrozole and palbociclib

(2:56)

ESMO 2020 Expert Video Report on CDK4 6i in the adjuvant treatment of breast cancer

(5:32)

Palbociclib combo therapies for advanced breast cancer

(1:49)

P-REALITY-X: Real-world, overall survival with palbociclib + aromatase inhibitor in HR+/HER2- MBC

(14:31)

Study of Palbociclib after CDK \u0026 Endocrine Therapy in ER+/HER2- Metastatic Breast Cancer

(6:29)

Palbociclib and Breast Cancer

(13:22)

Palbociclib Combination in Advanced/mBC Real-World Evidence Speaker: Prof. Jean-Marc Nabholtz

(37:26)